Skip to content
AI 인텔리전스May 15, 2026AI 인텔리전스
기사

TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results.

The company is developing novel therapies to overcome resistance to cancer immunotherapy.

Data Cube AI 편집팀출처: PR Newswire
01

출처 브리프

TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results. The company is developing novel therapies to overcome resistance to cancer immunotherapy.